In a clinical trial, the T2Bacteria Panel showed promise for rapidly and accurately diagnosing bloodstream infections or sepsis caused by five common bacteria. The test could be used in a clinical setting in place of blood cultures, which are insensitive and can take a long time to show results. How these findings will affect clinical practice is not yet determined. Findings from a diagnostic accuracy study are published in Annals of Internal Medicine.
* This article was originally published here
